Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancer
ConclusionThis post-marketing surveillance study further confirmed the safety and tolerability profile of trifluridine/tipiracil observed in a clinical study setting.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Drugs & Pharmacology | Japan Health | Oral Cancer | Study